InvestorWire NewsRoom

Articles

Articles Category: Biotechnology
Friday Apr 16, 2021 - 12:16 pm

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profileMescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort that produced a wave of cannabis product legalizationMescaline has historically defied…

Continue Reading

Monday Apr 12, 2021 - 1:02 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partnerXPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standardsThe Covid-ID Lab is designed to help beleaguered…

Continue Reading

Monday Apr 12, 2021 - 12:36 pm

Brain Scientific Inc. (BRSF) Changing the Landscape by Tackling Neurology Deserts

Distribution of neurologists across the U.S. is uneven with 20 states experiencing neurology desertsBrain Scientific has developed tools that help providers in neurology deserts provide access to neurological careWith explosion of telemedicine services and increased integration of advanced practice providers, neurologists' shortage may improve Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is directly tackling the shortage of neurologists in the United States with cutting-edge…

Continue Reading

Friday Apr 09, 2021 - 2:27 pm

RYAH Group Inc. Offers IoT Suite of Products Disrupting Future of Medicine

Every product features three parts: dosing device, formulation accessory and mobile appHIPPA-compliant cloud collects data along each step that is essential in tailoring personalized treatment planRYAH offers multi-product ecosystem that provides remote-health solutions in patient treatment RYAH Group a digital health-care analytics and technology company, has developed an ecosystem of IoT products in its mission to advance the world's transition to remote-health solutions and data…

Continue Reading

Thursday Apr 08, 2021 - 2:34 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commercialization Team Set to Launch Rapid POC COVID Test Solution

Bioscience technology accelerator XPhyto Therapeutics Corp. is working with development partner 3a-diagnostics GmbH to roll out its pandemic-related virus diagnostic tool for the European market planned in AprilThe test solution, dubbed “Covid-ID Lab,” received European regulatory approval last monthXPhyto’s product is designed to be portable and rapid in its response time to help decrease testing operation costs and increase convenience of useNews reports about the…

Continue Reading

Thursday Apr 08, 2021 - 1:11 pm

Brain Scientific Inc. (BRSF) Meeting the Needs of Neuro Research

BRSF is creating mobile, easy-to-use electroencephalogram (“EEG”) devices that enhance research integrityThere is an increasing desire to understand the brain’s capabilities and harness them for healingBrain Scientific provides a cost-efficient, pre-gelled, disposable and wireless solution that provides the same signal quality as the traditional wired EEG A growing consumer market for brain-computer interface (“BCI”) technology has some researchers worried about the quality of the data…

Continue Reading

Wednesday Apr 07, 2021 - 2:44 pm

Patients with Incurable Brain Cancers Find New Hope in University Study, Upcoming CNS Pharmaceuticals (NASDAQ: CNSP) Clinical Trial

Glioblastoma Multiforme (often known simply as GBM) is a fatal, incurable class of brain cancers that usually leaves patients only about 15 months to live once they are diagnosedA recent study by the Washington University School of Medicine found that the length of survivability appeared to improve when the standard chemotherapy regimen was given in the morning instead of the eveningBrain cancer drug developer CNS…

Continue Reading

Wednesday Apr 07, 2021 - 12:05 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Innovative Imaging Technology Overcoming Challenges Involving Bladder Cancer Visualization

90% of the cystoscopies performed on bladder cancer patients use white light, which cannot always detect cancer margins or tumors that lie flat against the bladder wall. The American Urology Association recommends blue light for cystoscopic procedures involving bladder cancer.Imagin Medical’s i/Blue Imaging System(TM) provides the simultaneous, side-by-side display of white light and blue light images, making it easier to visualize cancer margins and flat…

Continue Reading

Tuesday Apr 06, 2021 - 1:04 pm

Healthy Extracts Inc.’s (HYEX) “Live Life Young Again” Strategy Reflects The Company’s Continued Optimism For 2021

Healthy Extracts Inc. recently declared its 2020 Q4 results, with revenue growth at 71% over the previous yearThe company’s 2021 strategy “Live Life Young Again” aligns with its plant-based product range and its overall confidence for 2021Results of the clinical studies of the Fuel4Thought Brain Booster product were published in the renowned World Journal of Advanced Research and Reviews Healthy Extracts (OTCQB: HYEX), is engaged in…

Continue Reading

Thursday Apr 01, 2021 - 10:49 am

United Medical Equipment Business Solutions Network Inc. Positioned to Assist as Widespread Rapid Testing Gains Momentum

New York City ramps up rapid testing efforts, opens 11 rapid-testing sites; others to followMayor notes that low-cost, rapid-testing made available to public is key to accelerating economy's re-openingUME offers rapid -testing kits, provides products and services essential for curbing pandemic and jumpstarting economic recovery United Medical Equipment Business Solutions Network (“UME”), a trusted supplier of COVID-19 antigen and antibody testing kits, is offering a…

Continue Reading

Monday Mar 29, 2021 - 11:26 am

Predictive Oncology’s (NASDAQ: POAI) Helomics Exec Talks AI, Big Data and Biology During Podcast Appearance

Convergence of AI, big data and biology allows Helomics to test drugs on living tumor tissue rather than artificial systemsHelomics model evaluates multiple measurements in powerful multi-omics approach to cancer researchKnowledge encapsulated by Helomics AI is “gold dust,” says chief innovation officer Data, AI and biology come together at Helomics in a way that promises exciting things for the future, according to  Mark Collins, PhD and…

Continue Reading

Friday Mar 19, 2021 - 3:46 pm

United Medical Equipment Business Solutions Network Positioned to Assist as Widespread Rapid Testing Gains Momentum

New York City ramps up rapid testing efforts, opens 11 rapid-testing sites; others to followMayor notes that low-cost, rapid-testing made available to public is key to accelerating economy's re-openingUME offers rapid -testing kits, provides products and services essential for curbing pandemic and jumpstarting economic recovery United Medical Equipment Business Solutions Network (“UME”), a trusted supplier of COVID-19 antigen and antibody testing kits, is offering a…

Continue Reading

Friday Mar 19, 2021 - 2:14 pm

Predictive Oncology’s (NASDAQ: POAI) Skyline Medical Working on Gen 3 Fluid-to-Drain Liquid Waste Management System for Hospitals

Fluid management systems, accessories market forecast at 13.6% CAGR to $16.1 billion by 2025Skyline Medical’s STREAMWAY(R) System disrupts today’s standard of manually moving waste fluid for disposalSTREAMWAY Systems eliminates waste transport, disposal costs, equipment relocation and risk of exposure to potentially contaminated fluids. For every healthcare facility, particularly hospitals and surgical centers, disposal of waste fluids presents a unique set of challenges related not only…

Continue Reading

Friday Mar 19, 2021 - 12:41 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Remains on Schedule to bring in Bladder Cancer Imaging System to Market

Bladder cancer is the fourth most common cancer in men andexpected to cause more than 17,000 deaths in the United States this yearImagin Medical is advancing its patented bladder cancer visualization technology toward commercialization and FDA approval, expecting the technology to revolutionize blue light cystoscopy procedures and improve patient outcomes in the processImagin is funding its efforts with $2.165 million raised towards its convertible note…

Continue Reading

Wednesday Mar 17, 2021 - 2:02 pm

Imagin Medical (CSE: IME) (OTCQB: IMEXF), With Their Advanced i/Blue(TM) Imaging System, Closes Second Tranche of Convertible Note Offering

Imagin Medical is a surgical company focused on developing its i/Blue(TM) Imaging System, employing patented ultrasensitive imaging technologyThe i/Blue(TM) Imaging System is system compatible; system attaches to most endoscopesThe company recently closed the second tranche for the amount of US$1,415,500 of the Convertible Note offering Imagin Medical (CSE: IME) (OTCQB: IMEXF) is a surgical imaging company focused on advancing new methods of visualizing cancer during…

Continue Reading

Tuesday Mar 16, 2021 - 2:35 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set to Begin Enrolling Brain Cancer Drug Trial Participants

Brain cancer drug developer CNS Pharmaceuticals is finalizing preparations to begin March enrollment of patients in its potentially pivotal Phase 2 trial evaluating its promising lead candidate, Berubicin, for the overall survival improvement of glioblastoma (“GBM”) patientsGlioblastomas are a type of brain cancer that have continued to elude effective therapy over the past century of investigation, leaving patients with expectations of approximately 15 months of…

Continue Reading

Monday Mar 15, 2021 - 2:15 pm

Healthy Extracts Inc. (HYEX) Reports 71% Revenue Increase Backed by Industry Momentum

Healthy Extracts Inc. officially changed its name from Grey Cloak Tech Inc. on March 1, formalizing the company’s shift into the health products industryHealthy Extracts currently wholly owns two subsidiaries, BergaMet North America (“NA”) and Ultimate Brain Nutrients (“UBN”), and reported a revenue increase of 71% from $748,377 in 2019 to $1,276,559 in the 12 months ending December 31, 2020This revenue growth is consistent with…

Continue Reading

Monday Mar 15, 2021 - 12:17 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Revolutionary Technology a Cost Saver for Hospitals and Patients

White light cystoscopy (“WLC”) is the most commonly used procedure to detect non-muscle invasive bladder cancer (“NMIBC”)Despite its prevalence, WLC is not the most effective method and contributes to a high bladder cancer recurrence rateBlue light cystoscopy (“BLC”) is a more recent and highly effective method, but the high cost of equipment and skill level has impeded its uptake among hospitalsImagin Medical believes the i/Blue(TM)…

Continue Reading

Friday Mar 12, 2021 - 12:41 pm

Brain Scientific Inc. (BRSF) Meeting Need for Disposable Technology

COVID-19 has increased the need for disposable neurological technologyCurrently no way exists to ensure electrodes are free of contamination when using traditional reusable EEGsNeurological manifestations have presented themselves in 82% of hospitalized COVID-19 Brain Scientific (OTCQB: BRSF) is a commercial-stage, health-care company modernizing the brain diagnostic market through cutting-edge technologies. The company is fulfilling a growing need for improved brain monitoring that is cost efficient,…

Continue Reading

Thursday Mar 11, 2021 - 2:20 pm

Brain Scientific Inc. (BRSF) Teams Up with Ehave Inc. to Leverage Use of AI in Mental Health Space

BRSF signed MOU with leading provider of digital therapeutics for mental health sector to use data, AI to advance work in mental health disordersCompany will provide proprietary NeuroCap, NeuroEEG devices to collect, transfer data from patientsCollaboration could expand into a number of clinical and commercial applications Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company developing products related to the brain including neurology, AI and machine…

Continue Reading

Tuesday Mar 09, 2021 - 3:26 pm

Predictive Oncology Inc. (NASDAQ: POAI) Hits Milestone in AI Platform Development for Ovarian Cancer

Cancer screenings, treatments declined during COVID-19 pandemic, highlighting need for personalized therapies to improve outcomesComprehensive genomic, transcriptomic sequencing of patient samples complete, patient outcome data obtained from UPMC-MageeProject is template for future partnerships with other healthcare institutions to expand POAI’s AI-driven clinical models to other cancers The consequences of COVID-19 sent shock waves throughout the healthcare sector in more ways than just the direct impact…

Continue Reading

Monday Mar 08, 2021 - 10:49 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Takes Bladder Cancer Battle to Next Level

Imagin Medical has developed a technology, currently entering the manufacturing stage, which it believes will revolutionize bladder cancer surgical imagingThe company’s technology, the i/Blue Imaging System, can display blue and white light images of the bladder side-by-side simultaneously, allowing surgeons greater ability to detect and remove tumorsImagin has raised a $2.165 million convertible note offering to fund the company during the manufacturing phase of its…

Continue Reading

Friday Mar 05, 2021 - 12:35 pm

Brain Scientific Inc. (BRSF) Making EEGs Accessible in Emergency Departments

Head CTs, MRIs are most-used but not most-effective tool for head trauma or neurological issues in triageEEG changed clinical management of 76.2% of patients, even when CT or MRI was availableBrain Scientific has overcome key barriers causing EEG underuse in emergency medicine Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company, is making EEGs accessible in emergency departments (“ED”) with cutting-edge tech that bridges the widening…

Continue Reading

Friday Mar 05, 2021 - 12:20 pm

Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M

POAI completes two separate fundraising initiatives: private placement, direct offering.Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively.Predictive Oncology plans to use funds to pay off debt as well as for working capital, general corporate purposes. Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced two funding initiatives that together…

Continue Reading

Friday Mar 05, 2021 - 11:13 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels

CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compoundBerubicin is CNSP’s lead, novel anthracycline candidate for the treatment of glioblastoma multiforme (“GBM”) that was the subject of a previously conducted Phase 1 clinical trial, which had a clinical benefit response rate of 44%CNSP has sublicensed Berubicin to WPD Pharmaceuticals in 31 countries primarily in eastern Europe and western AsiaWPD plans to conduct…

Continue Reading

Thursday Mar 04, 2021 - 1:29 pm

RYAH Group Committed to Advancing Telehealth in HIPAA-Compliant Environment

Telehealth sector going through explosive growth; patients' data protection remains key challengeAlthough relaxed due to COVID-19 outbreak, HIPAA guidelines protecting patients' data security, privacy likely to tighten as pandemic abatesRYAH appears ready to respond to strict data security requirements, uses medical data in a HIPAA-compliant setting Telehealth is becoming increasingly popular with patients and doctors alike, but securing the integrity of patient information remains critical.…

Continue Reading

Thursday Mar 04, 2021 - 11:45 am

Brain Scientific (BRSF) Developing State-of-the-Art AI Diagnostic Analytics

BRSF working to improve diagnostics by leveraging AI and machine learningCloud-based infrastructure, AI-assisted diagnostic analysis is in development phaseBrain Scientific creating long-term monitoring capabilities that leads to collection of essential biomarkers Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company focused on developing innovative and proprietary medical devices and software, is working on developing state-of-the-art AI diagnostic analytics. The company’s two FDA-cleared products — the NeuroCap(TM)…

Continue Reading

Wednesday Mar 03, 2021 - 12:26 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Reimagines Technology to Create Better Cancer Outcomes

Archaic technology contributes to dismal recurrence rate in bladder cancerImagin Medical revolutionizes the way surgeons can visualize cancer to better identify, and remove during surgeryThere is potential to extend this technology to virtually other endoscopic procedures The battle against cancer is too often set back by crushing blows of recurrence. The disease is insidious. If every single malignant cell of a tumor is not completely…

Continue Reading

Tuesday Mar 02, 2021 - 2:56 pm

United Medical Equipment Business Solutions Network Inc. Stands to Benefit as Health Officials Call for More at Home Testing

Testing is more important than ever, medical experts claim, urging government to speed up widespread testingTens of millions of rapid, at-home tests may be needed every dayUME offers rapid testing kits to help end the pandemic, ready to seize the opportunity The U.S. government has announced plans to roll out more than 60 million home test kits to stop the COVID-19 virus from spreading (https://ibn.fm/O89KJ).…

Continue Reading

Tuesday Mar 02, 2021 - 2:12 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic About Upcoming Berubicin Trials After IND Approval

Berubicin is CNS Pharmaceuticals’ lead product candidate for treatment of Glioblastoma Multiforme, and has the potential to be the first anthracycline to cross the blood-brain barrier based on limited results from a Phase 1 trialThe market for GBM treatment is estimated to reach $3.3 billion in 2024, growing at a CAGR of 17.4%CNS, in collaboration with sublicensee partner WPD Pharmaceuticals, is currently planning three Berubicin…

Continue Reading

Friday Feb 26, 2021 - 1:49 pm

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Releases Record-Breaking Gross Revenue for January 2021

Company reports record gross revenues of C$1,089,502 last month“It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” states CEORecord revenue comes during one of slowest e-commerce periods of year, highlighting impact the company has in the plant-based marketplace PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) saw record gross revenues last month (https://ibn.fm/qro4v).…

Continue Reading

Friday Feb 26, 2021 - 1:36 pm

Predictive Oncology Inc. (NASDAQ: POAI) Receives ‘Buy’ Rating from Litchfield Hills Research in First Analyst Coverage Report

Calling POAI undervalued, Litchfield initiates coverage of Predictive Oncology with Buy rating, $3 price targetThe drug industry is changing as tools and technology to tailor drugs emerge, regulatory bodies focus on patients’ experiences, perspectives, needsLitchfield report notes several POAI strengths under “Investment Thesis” section A growing number of companies and health providers alike are paying attention to what the FDA is calling patient-focused drug development…

Continue Reading

Friday Feb 26, 2021 - 12:15 pm

Better Cancer Outcomes Possible with Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology

Imagin Medical Inc.’s patented i/Blue System revolutionizes the way surgeons are able to visualize the bladder and identify cancers during surgeryThe breakthrough technology of Imagin Medical’s i/Blue Imaging System rectifies the limitations of both white and blue light cystoscopiesBladder cystoscopies first target - multiple other endoscopic procedures planned Science and technology have continued to make striking advancements in cancer therapeutics and treatment protocols, improving upon…

Continue Reading

Thursday Feb 25, 2021 - 12:57 pm

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) Reports Its Plant-Based Biopesticide Has Positive Impact on Soil Health

Studies confirm natural active ingredient, which is in MustGrow’s biopesticide, has a positive impact on soil healthSoil micro-organisms play crucial role in soil fertility, plant healthMustGrow's safe, effective natural biopesticide is plant based, derived from the mustard seed's natural defense mechanism MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has released study findings that confirm that the active ingredient in its mustard plant-based technology actually has…

Continue Reading

Wednesday Feb 24, 2021 - 3:18 pm

United Medical Equipment Business Solutions Network Inc. Providing Solutions to Combat the Spread of COVID-19

UME is trusted supplier of FDA-approved antibody, antigen test kitsUnited moved quickly to address growing needs created by COVID-19Company dedicated to providing guidance to aging population, their families and medical staff supporting them United Medical Equipment Business Solutions Network is a company focused on the needs of aging patients and veteran communities as well as those impacted by the COVID-19 pandemic. United is a trusted…

Continue Reading

Wednesday Feb 24, 2021 - 1:33 pm

PlantX Life Inc.’s (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Collaboration with Farm Cup Coffee Designed to Boost Brand, Reach Customers and Inspire Lifestyles

PlantX to display and sell its indoor plants at Farm Cup Coffee’s highly attractive West Hollywood locationThe careful partnership aligns perfectly with PlantX’s commitment to supporting healthy lifestyles and community empowermentPlantX opens wide the potential of indoor plants, making it both easy and appealing to discover what the world of plants can provide As the digital face of the plant-based community, PlantX Life (CSE: VEGA)…

Continue Reading

Wednesday Feb 24, 2021 - 1:18 pm

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiaries Ink Significant Contract, Announce Sale of Media to Top Medical Centers

POAI subsidiary inks contract with significant pharmaceutical companyTumorGenesis announces sale of media to research medical centers in New York City, BostonPotential market for 3D cancer cell culture media expected to reach $3.2 billion sales worldwide by 2027 Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its wholly owned subsidiaries, Soluble Biotech,…

Continue Reading

Monday Feb 22, 2021 - 12:44 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advances Rapid COVID Test System, Expands Psychedelic Medicine Programs

Life sciences industry accelerator XPhyto Therapeutics Corp. has developed a timeline for the approval and rollout of a rapid, portable COVID-19 test it expects to become available by April in EuropeXPhyto’s Covid-ID Lab system is designed to help industries economically devastated by the pandemic to form strategies based on quick and accurate testing, particularly the travel industryThe company intends to use its test tech partnership…

Continue Reading

Monday Feb 22, 2021 - 11:57 am

Convertible Note Progress Brings Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) Closer to Commercialization of New Surgical Tech

Imagin Medical Inc. announced that it has now raised $2.165 million of the recent its convertible note offeringThe closing of the latest funding tranche will support the company’s progress toward the commercialization of its revolutionary bladder cancer visualization technology once final FDA approval is grantedWith better viewing options, the technology is designed to make it easier for surgeons to detect the full parameters of bladder…

Continue Reading

Monday Feb 22, 2021 - 10:30 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Committed to Developing New Generation Alternatives to Current Standard of Care for Anxiety Disorders

American Psychiatric Association poll reveals 62% of respondents have anxiety about COVID-19Recent FDA Drug Safety Communication requires updated Boxed Warning for benzodiazepines commonly used to treat anxiety disordersVTGN is committed to developing and commercializing PH94B, a first-in-class pherine nasal spray with potential to go beyond the current standard of care for acute treatment of social anxiety disorder and other anxiety-related disorders Anxiety induced by the…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up NetworkNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).